News and Announcements
D Coin’s parent company DC Two to receive government funding for new ‘behind the grid’ data centre
- Published October 12, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- DC Coin’s parent company DC Two receives government grant for ‘behind the grid’ data centre.
- The data centre will be the first in Australia to be powered from renewable energy sources.
- DC Two’s project was one of eight projects chosen for the funding.
D Coin are pleased to announce that their parent company DC Two has been successfully approved as one of the first recipients of The Collie Futures Small Grants Program.
DC Two proposed to build a ‘behind the grid’ data centre in August and last week received a government grant for the project.
The data centre will be situated in the town of Collie, 200km south of Perth.
The McGowan Government is investing $678,000 in the development of eight Collie projects as part of efforts to further unlock the town’s economic potential.
The data centre will be the first in Australia to be powered from renewable energy sources.
DC Two will use local businesses such as electricians and labourers, to work on the data centre in the hope of generating more jobs.
The data centre has been designed specifically for crypto and Bitcoin mining.
About D Coin
D Coin is a unique vertically integrated digital currency business, owned and operated in Australia offering a digital asset investment fund open to retail, wholesale and commercial investors.
The fund operates in the digital asset realm combining multiple proprietary activities across technology, financial markets and cryptocurrency, fully immersing our investors into the fastest asset growth class available.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
